MedTrace Logo

Pain Management After Adductor Canal Block for Total Knee Arthroplasty

NCT06086483 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 361

Last updated 2023-10-17

No results posted yet for this study

Summary

This randomized, double-blinded, placebo-controlled trial sought to evaluate the efficacy of the iPACK block with Adductor Canal Block on postoperative pain, functional recovery and NLR and PLR levels.

Conditions

Interventions

DRUG

Ropivacaine 0.2% Injectable Solution

20 mL 0.5% ropivacaine was injected into the PENG block 20 mL 0.5% ropivacaine was injected into the Adductor Canal block

DRUG

0.9%sodium chloride

20 mL 0.9% sodium chloride was injected into the PENG block 20 mL 0.5% sodium chloride was injected into the Adductor Canal block

Sponsors & Collaborators

  • Poznan University of Medical Sciences

    lead OTHER

Principal Investigators

  • Zbigniew Żaba, Ph.D. · Department of Emergency Medicine Clinic

  • Malgorzata Domagalska, Ph.D. · Department of Palliative Medicine, University of Medical Sciences, Poznań, Poland

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-06-18
Primary Completion
2022-07-20
Completion
2023-08-24

Countries

  • Poland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06086483 on ClinicalTrials.gov